Cardiology

LDL-C still high in autosomal recessive hypercholesterolemia

(HealthDay)—For patients with autosomal recessive hypercholesterolemia (ARH), low-density lipoprotein cholesterol (LDL-C) levels remain high despite intensive treatment, according to a study published in the Jan. 23 issue ...

Immunology

Immune response to bacteria—distinguishing helpers from harmers

Some staphylococcus bacteria live peacefully on human skin and membranes in a mutually beneficial relationship with their host, while others are able to exist far from a human host in soil or in water. When we come into contact ...

Cardiology

Measuring plasma PCSK9 may ID resistance to PCSK9 inhibitors

(HealthDay)—Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) may help assess apparent resistance to PCSK9 inhibitors, according to a research letter published online Nov. 28 in the Annals of Internal ...

Diabetes

Anagliptin effect on LDL in T2DM via ApoB-100 synthesis

(HealthDay)—In patients with type 2 diabetes being treated with a dipeptidyl peptidase-4 inhibitor (DPP4-I), use of anagliptin (ANA) may improve low-density lipoprotein cholesterol (LDL-C) levels, with the effect mediated, ...

Cardiology

ApoB levels more closely tied to reduced CVD events than LDL

(HealthDay)—Clinical benefit of reduced low-density lipoprotein cholesterol (LDL-C) levels may depend on the corresponding reduction in apolipoprotein B (apoB)-containing lipoprotein particles, according to a study published ...

page 21 from 38